Scpharmaceuticals Performance
| SCPHDelisted Stock | USD 5.67 0.01 0.18% |
The entity has a beta of 0.0, which indicates not very significant fluctuations relative to the market. the returns on MARKET and Scpharmaceuticals are completely uncorrelated. Scpharmaceuticals right now has a risk of 0.0%. Please validate Scpharmaceuticals daily balance of power and period momentum indicator , to decide if Scpharmaceuticals will be following its existing price patterns.
Risk-Adjusted Performance
Weakest
Weak | Strong |
Over the last 90 days Scpharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. Despite fairly strong basic indicators, Scpharmaceuticals is not utilizing all of its potentials. The recent stock price confusion, may contribute to short-horizon losses for the traders. ...more
| Begin Period Cash Flow | 46.8 M | |
| Total Cashflows From Investing Activities | 29.3 M |
Scpharmaceuticals |
Scpharmaceuticals Relative Risk vs. Return Landscape
If you would invest 567.00 in Scpharmaceuticals on November 25, 2025 and sell it today you would earn a total of 0.00 from holding Scpharmaceuticals or generate 0.0% return on investment over 90 days. Scpharmaceuticals is currently does not generate positive expected returns and assumes 0.0% risk (volatility on return distribution) over the 90 days horizon. In different words, 0% of stocks are less volatile than Scpharmaceuticals, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Scpharmaceuticals Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Scpharmaceuticals for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Scpharmaceuticals can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Scpharmaceuticals is not yet fully synchronised with the market data | |
| Scpharmaceuticals has a very high chance of going through financial distress in the upcoming years | |
| The company reported the previous year's revenue of 36.33 M. Net Loss for the year was (85.15 M) with profit before overhead, payroll, taxes, and interest of 34.21 M. | |
| Scpharmaceuticals currently holds about 55.85 M in cash with (70.54 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 2.04. | |
| Over 80.0% of the company shares are owned by institutional investors |
Scpharmaceuticals Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Scpharmaceuticals Stock often depends not only on the future outlook of the current and potential Scpharmaceuticals' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Scpharmaceuticals' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 44.5 M | |
| Cash And Short Term Investments | 75.7 M |
Scpharmaceuticals Fundamentals Growth
Scpharmaceuticals Stock prices reflect investors' perceptions of the future prospects and financial health of Scpharmaceuticals, and Scpharmaceuticals fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Scpharmaceuticals Stock performance.
| Return On Equity | -9.34 | |||
| Return On Asset | -0.57 | |||
| Profit Margin | (1.84) % | |||
| Operating Margin | (0.89) % | |||
| Current Valuation | 315.46 M | |||
| Shares Outstanding | 53.68 M | |||
| Price To Book | 28.45 X | |||
| Price To Sales | 6.09 X | |||
| Revenue | 36.33 M | |||
| EBITDA | (77.43 M) | |||
| Cash And Equivalents | 55.85 M | |||
| Cash Per Share | 2.04 X | |||
| Total Debt | 52.69 M | |||
| Debt To Equity | 0.32 % | |||
| Book Value Per Share | (0.40) X | |||
| Cash Flow From Operations | (70.54 M) | |||
| Earnings Per Share | (1.81) X | |||
| Total Asset | 107.52 M | |||
| Retained Earnings | (366.49 M) | |||
About Scpharmaceuticals Performance
By evaluating Scpharmaceuticals' fundamental ratios, stakeholders can gain valuable insights into Scpharmaceuticals' financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Scpharmaceuticals has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Scpharmaceuticals has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements. Please also refer to our technical analysis and fundamental analysis pages.
scPharmaceuticals Inc., a pharmaceutical company, engages in the development and commercialization of various pharmaceutical products. The company has a development agreement with West Pharmaceutical Services, Inc. for development of single use SmartDose device. scPharmaceuticals Inc. was incorporated in 2013 and is headquartered in Burlington, Massachusetts. SC Pharmaceuticals operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 26 people.Things to note about Scpharmaceuticals performance evaluation
Checking the ongoing alerts about Scpharmaceuticals for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Scpharmaceuticals help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Scpharmaceuticals is not yet fully synchronised with the market data | |
| Scpharmaceuticals has a very high chance of going through financial distress in the upcoming years | |
| The company reported the previous year's revenue of 36.33 M. Net Loss for the year was (85.15 M) with profit before overhead, payroll, taxes, and interest of 34.21 M. | |
| Scpharmaceuticals currently holds about 55.85 M in cash with (70.54 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 2.04. | |
| Over 80.0% of the company shares are owned by institutional investors |
- Analyzing Scpharmaceuticals' financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Scpharmaceuticals' stock is overvalued or undervalued compared to its peers.
- Examining Scpharmaceuticals' industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Scpharmaceuticals' management team can have a significant impact on its success or failure. Reviewing the track record and experience of Scpharmaceuticals' management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Scpharmaceuticals' stock. These opinions can provide insight into Scpharmaceuticals' potential for growth and whether the stock is currently undervalued or overvalued.
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in employment. You can also try the Stocks Directory module to find actively traded stocks across global markets.
Other Consideration for investing in Scpharmaceuticals Stock
If you are still planning to invest in Scpharmaceuticals check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Scpharmaceuticals' history and understand the potential risks before investing.
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets |